Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage and Intent Among Adults Aged 18-39 Years - United States, March-May 2021
Overall, 34% of adults aged 18-39 years reported having received a COVID-19 vaccine. Adults aged 18-24 years, as well as non-Hispanic Black adults and those with less education, no health insurance, and lower household incomes, had the lowest reported vaccination coverage and intent to get vaccinated. Concerns about vaccine safety and effectiveness were commonly cited barriers to vaccination.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423690
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021
By May 22, 2021, 57% of U.S. adults aged 18 and older had received ≥1 COVID-19 vaccine doses; coverage was lower and increased more slowly over time among younger adults. If the current rate of vaccination continues through August, coverage among young adults will remain substantially lower than among older adults.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423689
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021
As of May 2021, 16% of pregnant people identified in CDC's Vaccine Safety Datalink had received ≥1 dose of a COVID-19 vaccine during pregnancy in the U.S. Vaccination was lowest among Hispanic people (12%), non-Hispanic Black people (6%), and people aged 18-24 years (6%), and highest among non-Hispanic Asian people (25%) and people aged 35-49 years (23%).
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423566
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421438
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12-25 Years Before and During the COVID-19 Pandemic - United States, January 2019-May 2021
During the COVID-19 pandemic, emergency department (ED) visits for suspected suicide attempts increased among adolescents aged 12-17 years, especially girls. During February-March 2021, suspected suicide attempt ED visits were 51% higher among girls aged 12-17 years than during 2019; among boys aged 12-17 years, suspected suicide attempt ED visits increased 4%.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423473
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021
This report describes an investigation in Maryland of two linked clusters of COVID-19 cases identified as the B.1.351 variant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421458
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021
The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421416
Etiketler:


EklenmeTarihi: 18 Ocak 2022, Salı, 00:09
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021
Twenty-two possible breakthrough SARS-CoV-2 infections occurred among fully vaccinated persons ≥14 days after their second dose of COVID-19 vaccine. Two thirds of persons were asymptomatic. A minority of persons with breakthrough infection experienced mild to moderate COVID-19-like symptoms; two COVID-19-related hospitalizations and one death occurred. No facility-associated secondary transmission was identified.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420772
Etiketler: